DELTA – integrateD diagnostic solution for EarLy deTection of oesophageal cAncer.

Project DELTA will assess the feasibility and practical implementation steps of introducing CytospongeTM – TFF3 as a triage test for endoscopy to identify Barrett’s oesophagus, early cancer and other oesophageal conditions.

BEST2 – Evaluation of a Non-Endoscopic Immunocytological Device (Cytosponge) for Barrett’s Esophagus Screening in a Case-Control Study (BEST2).

The Barrett’s oEsophagus Screening Trial  is looking at whether a new device called the Cytosponge coupled with a molecular test would offer a suitable alternative to diagnose Barrett’s Oesophagus in the general population.

Close Bitnami banner